Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "sow" return 17 results.
Making the Diagnosis >
Diagnosis is required in a farm, where the disease was not yet properly described and the pathogen was not identified.
Repro Range Launching, Vietnam >
Key event in Vietnam for 2014 to launch full range of Ceva Reproduction Products
Coglapest® >
Frequently Asked Questions
Clinical efficiency of Vetrimoxin® LA in the control of early mortality in suckling piglets >
Prophylactic use of efficient antibiotics can reduce the incidence of the disease and decrease the losses due to mortality or crushing of weak, sick piglets. The aim of this study was to evaluate the...
VETRIMOXIN® LA - Technical profile >
Vetrimoxin® LA is the leading product in the Ceva anti-infective range. Within the group of historical antibiotics, the product has an extensive experience in the market as leader in its segment being...
Overview of porcine immune defenses and immunity to Mycoplasma hyopneumoniae infection >
The pig relies on multiple defenses to protect itself against microbial invasion. Understanding these immune defenses will help the producers to find the suitable solution to control the diseases in p...
2. >
Actinobaccilus pleuropneumoniae
Mycoplasma hyopneumoniae: strain diversity and control measures >
Control measures for infections with Mycoplasma hyopneumoniae should focus on optimisation of management practices, and if these are not sufficient, antimicrobial medication and/or vaccination can be...
Coglapix® - Economic benefit study versus an antibiotic in the control of A.P. >
The Vaccine group (with Coglapix®) and Antibiotic group have the higher performance and more profit than the Control group. Although the similar performance, the economic impact given by the Vaccine g...
Mycoplasma hyopneumoniae - still a major challenge >
Mycoplasma hyopneumoniae cannot be ignored warns JOHN BAKER. Vaccination provides immediate improvement in the control of this costly disease and correcting problems in environment and management will...